VNRX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Volitionrx Ltd

NYSE MKT | VNRX

0.43

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$53.34M

Market Cap

-

P/E Ratio

-0.24

EPS

$0.94

52 Week High

$0.39

52 Week Low

HEALTHCARE

Sector

VNRX Chart

Recent Chart
Price Action

VNRX Technicals

Tags:

VNRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.2M
Total Revenue $1.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$27M
Selling General And Administrative $13M
Research And Development $14M
Operating Expenses $28M
Investment Income Net -
Net Interest Income -$330K
Interest Income $9.9K
Interest Expense $340K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$26M
Net Income -$27M

Revenue & Profitability

Earnings Performance

VNRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $9.4M
Total Current Assets $4.1M
Cash And Cash Equivalents At Carrying Value $3.3M
Cash And Short Term Investments $3.3M
Inventory -
Current Net Receivables $111K
Total Non Current Assets $5.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $314K
Intangible Assets Excluding Goodwill $314K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $682K
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $7.8M
Current Accounts Payable $2.8M
Deferred Revenue -
Current Debt -
Short Term Debt $1.1M
Total Non Current Liabilities $28M
Capital Lease Obligations $1M
Long Term Debt $4M
Current Long Term Debt $860K
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.8M
Other Current Liabilities $3.7M
Other Non Current Liabilities -
Total Shareholder Equity -$25M
Treasury Stock -
Retained Earnings -$230M
Common Stock $96K
Common Stock Shares Outstanding $87M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$26M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $574K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$574K
Cashflow From Financing $8.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.2M
Total Revenue $1.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$27M
Selling General And Administrative $13M
Research And Development $14M
Operating Expenses $28M
Investment Income Net -
Net Interest Income -$330K
Interest Income $9.9K
Interest Expense $340K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$26M
Net Income -$27M

VNRX Profile

Volitionrx Ltd Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

VolitionRx Limited (VNRX) is an innovative multinational epigenetics company based in Austin, Texas, dedicated to developing blood-based diagnostic tests aimed at improving cancer detection and other disease diagnoses globally. Utilizing its proprietary Nu.Qâ„¢ platform, VolitionRx focuses on creating advanced, non-invasive diagnostic solutions that seek to enhance patient outcomes through early disease detection. Positioned at the cutting edge of the expanding epigenetics market, the company is strategically positioned to address the increasing demand for accurate and reliable diagnostic tools in oncology and beyond, signaling significant growth potential.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
CORZ
+2.23%
$19.23
UAMY
-7.74%
$12.39
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
CORZ
+2.23%
$19.23
UAMY
-7.74%
$12.39
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.